Justin O. Reliford


HIGHLIGHTS:

  • Lawdragon 500 Leading Plaintiff Financial Lawyer (2021-2022)
  • Super Lawyer, Rising Star (2013-2017)

BIO:

Justin Reliford co-leads the Firm’s Delaware office and is a partner in the Firm’s Corporate Governance and Shareholders Rights practice group.

Mr. Reliford is one of the nation’s leading corporate governance and M&A litigators, with extensive experience prosecuting claims in state and federal courts across the country.  Mr. Reliford is a true believer in the value of strong corporate governance, accountability, and a fair market.  Throughout his career, Mr. Reliford has helped recover nearly a billion dollars for stockholders and corporations to remedy alleged misconduct by corporate directors and officers.  Having previously worked as a labor and employment litigator, Mr. Reliford has counseled sophisticated clients through a wide range of class and collective actions in high-stakes litigation.  Mr. Reliford’s background provides a unique insight into the concerns and motivations of corporate constituents at all levels, which Mr. Reliford relies upon to secure significant litigation outcomes and sound business solutions.

Mr. Reliford is currently admitted to practice in Pennsylvania, New Jersey, and New York only.

REPRESENTATIVE CASES:

  • In re Cardinal Health Inc. Derivative Litig., 2:19-cv-02491 (S.D. Ohio) ($124 million settlement of opioid-related director oversight claims)
  • In re Tesla Motors, Inc. S’holder Litig., C.A. No. 12711-VCS (Del. Ch.) ($60 million settlement of breach of fiduciary duty claims in connection with a corporate transaction)
  • Ark. Teacher Ret. Sys. v. Alon USA Energy Inc., C.A. No. 2017-0453-KSJM (Del. Ch.) ($44.75 million settlement of merger-related breach of fiduciary duty claims)
  • Weiss v. Burke, et al., C.A. No. 2020-0364-PAF (Del. Ch.) ($17.5 million settlement of stockholder claims in connection with HGGC’s acquisition of Nutraceutical Inc.)
  • In re Allergan Inc. Proxy Violation Sec. Litig., No. 8:14-cv-02004 (C.D. Cal.) ($250 million settlement of insider trading claims under the Williams Act)
  • In re Dole Food Co., Inc. S’holder Litig., C.A. No. 8703-VCL (Del. Ch.) ($148 million settlement following post-trial ruling in plaintiffs’ favor on breach of fiduciary claims in connection with a take-private transaction)